CAPR
Capricor Therapeutics Inc
7.80$
-2.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +28.8% | +13.1% | -68.6% | +51.9% | -15.9% | +1.0% | -45.7% | +195.6% | -64.4% | +78.0% | -65.4% | +56.3% | -16.4% | -73.1% | -66.2% | +242.9% | -29.4% | +400.0% | -100.0% | – | -100.0% | – | – | -39.7% | +211.1% | +31.2% | +57.9% | +95.4% | -59.4% | -19.1% | -43.1% | +392.1% | -100.0% | – | – | – | – | – | – | |
| – | -43.6% | +22.2% | -4.0% | -40.5% | +35.2% | +7.1% | +25.7% | -7.6% | -9.0% | -36.4% | -9.2% | -47.8% | -3.4% | +39.4% | +66.9% | +36.4% | +4.4% | +20.1% | +6.1% | -28.1% | +69.6% | +20.0% | -2.9% | -96.8% | +15.8% | +4,039.4% | -96.8% | +11.4% | +3,495.4% | +11.7% | +12.6% | -5.6% | +23.3% | +30.0% | +16.6% | -7.7% | – | – | – | – | |
| – | +0.0% | +28.8% | +13.1% | -68.6% | -752.0% | – | +1.0% | -45.7% | +195.6% | -64.4% | +59.3% | -61.3% | -527.0% | – | – | – | – | – | +400.0% | -1,331.8% | – | – | – | – | -39.7% | +211.1% | +31.2% | +57.9% | -65.3% | -388.4% | – | – | – | – | – | – | – | – | – | – | |
| – | -43.6% | +22.2% | -4.0% | -40.5% | +35.2% | +7.1% | +25.7% | -7.6% | -9.0% | -36.4% | -9.2% | -47.8% | -3.4% | +39.4% | +66.9% | +36.4% | +4.4% | +20.1% | +6.1% | -28.1% | +69.6% | +20.0% | -2.9% | +10.9% | +13.2% | +22.9% | +15.1% | +13.7% | -0.9% | +11.7% | +12.6% | -5.6% | +23.3% | +30.0% | +16.6% | -7.7% | +13.6% | +18.3% | +5.4% | – | |
| – | -8.4% | +3.0% | +4.9% | -12.7% | +13.7% | +12.3% | -15.3% | +6.9% | -12.2% | -11.6% | -14.8% | +9.6% | -3.9% | +29.8% | +41.5% | -19.2% | +14.7% | +27.6% | -6.1% | +0.6% | +17.5% | +28.3% | -13.2% | +8.8% | +8.9% | +22.3% | -19.5% | +5.7% | +17.9% | +18.7% | -24.9% | +13.3% | +23.4% | +42.0% | -6.5% | +4.5% | -2.5% | +58.3% | +54.0% | – | |
| – | -39.3% | +23.6% | -1.6% | -32.5% | +11.1% | +24.6% | +11.8% | -3.9% | -10.0% | -29.5% | -11.2% | -28.5% | -50.5% | +29.8% | +41.5% | -19.2% | +14.7% | +248.4% | +1.6% | -65.9% | +17.5% | +28.3% | -13.2% | +242.4% | +11.9% | +23.8% | +4.4% | +11.9% | -73.7% | +18.7% | -24.9% | +13.3% | +23.4% | +42.0% | -6.5% | +4.5% | +392.1% | +26.1% | +16.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.2% | +2.3% | +0.2% | +2.0% | -25.4% | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -99.9% | +895.3% | -20.3% | +826.9% | +41,924.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -129.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.2% | +52.6% | -35.2% | +8.6% | -38.3% | -174.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -393,129.2% | – | – | – | +100.0% | +25.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -129.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -129.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -103.4% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.